It is currently estimated that more than 400,000 Americans and 2.5 million people worldwide are living with MS. In order for MS patients to continue receiving the best care for generations to come, it is imperative that the workforce of MS healthcare professionals be large enough to meet the growing demands.
The CMSC has focused on aggressively recruiting and training the community of dedicated specialists in the field. Our goal is to encourage medical students and other healthcare professionals to choose MS as an initial focus of study or to pursue more advanced and specialized training as part of their studies. Recipients are able to apply new skills and share knowledge with colleagues within their academic institution and practice settings.
By increasing the number of well-trained healthcare professionals in MS, and ensuring that they are well-trained and well-prepared, we can continue to deliver the finest care, improve the quality of life for patients and families living with MS, and ultimately find a cure.
For the CMSC to continue providing comprehensive care and specialized services to MS patients, it is paramount that the community of MS professionals has access to specialized training.
The Foundation of the CMSC funds scholarships for:
- Neurology residents;
- Research Scholarships for medical students.
Recipients of Neurology Resident annual meeting scientific scholarships are able to apply new skills and share knowledge with colleagues within their academic institutions and practice settings.
FCMSC Medical Student Research Scholars and Mentors
One of the most promising ways to build a committed and competent MS Workforce of the Future is to expose students to new challenges under the mentorship of top-tier experts. The MS Summer Research Scholar program pairs medical students with an impressive group of leading MS research and clinical experts for two-month projects covering a wide spectrum of MS research. Click here to read personal feedback from FCMSC Research Scholars and their mentors.
These students are invited to present the results of their work at the following year’s CMSC annual scientific meeting, encouraging a new pool of passionate MS professionals.
|FCMSC Medical Student Research Scholarship Presenters Annual Meeting 2018|
|Scholar||Research Institution||Research Project|
|Kimberley Chang||University of British Columbia||Myelin Water Fraction as a Potential Marker of Progression in Primary Progressive Multiple Sclerosis|
|Mindy Chen||University of Maryland- Baltimore||Comparison of Kinematic and Clinical Measures of Arm Movement in Multiple Sclerosis and Other Neurological Disorders|
|Jonathan Ciriello||University of Maryland School of Medicine||Phosphorylated SIRT1 as Biomarker of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis|
|Cheryl Fields||Holy Name MS Center||The Ratio of 1st and 2nd Metatarsal Head Plantar Loading in Individuals with Multiple Sclerosis and Controls|
|Claudia Gambrah- Sampaney||Children’s Hospital of Philadelphia, University of Philadelphia||Early Life Nutrition and Risk of Pediatric Multiple Sclerosis|
|Lauren Hall||University of Massachusetts Medical School||The Role of Gut Microbiota in Relapsing Multiple Sclerosis|
|Jamie Head||University of British Columbia||Time Spent with Adequate Supply of Dimethyl Fumarate in a Specialty Pharmacist-Led Monitoring Program Versus Standard Dispensation in British Columbia|
|Alexander Liam Pearson||Hospital for Sick Children’s MS and Demyelinating Disorders Center||Moderate-to-Vigorous Physical Activity is Positively Associated with the Retinal Nerve Fibre Layer Thickness in Pediatric Multiple Sclerosis|
|Pauline Luczynski||Centre for Brain, UBC Hospital, University of British Columbia||Coexistence of Multiple Sclerosis and Alzheimer’s Disease|
|Samantha Roman||Johns Hopkins University School of Medicine||Metabolomic Changes Associated with Calorie Restriction in People with MS & Metabolomic Changes Associated with a Time-Restricted Diet in People with MS|
|Lewin Staine||Multiple Sclerosis Research Group, McGovern Medical School, UTHealth||Enhanced Regional Cerebral Perfusion Following Acetazolamide: Preliminary Results|
The Foundation of the CMSC salutes the supporters of MS Workforce of the Future initiatives:
- AbbVie, Inc.
- Bayer HealthCare Pharmaceuticals, Inc.
- Celgene Corporation
- EMD Serono, Inc.
- Inserra Family
- Mallinckrodt Pharmaceuticals
- Novartis Pharmaceuticals
- Sanofi Genzyme
With your help and support of the Foundation of the CMSC, we can ensure that future generations of people with MS will receive the quality healthcare they need and deserve.